NCT01210079View on ClinicalTrials.gov

Hyperalgesia in Methadone-Maintained Patients: Can it be Treated?

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

March 31, 2008

Study Completion Date

May 31, 2010

Conditions
Opioid-Induced Hyperalgesia
Interventions
DRUG

Gabapentin;

Gabapentin titrated to daily dose of 2400mg PO over 1 week with established dose taken daily for 5 weeks.

DRUG

Placebo

Placebo titrated over 1 week with established dose taken daily for 5 weeks.

Trial Locations (1)

90095

UCLA School of Nursing, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT01210079 - Hyperalgesia in Methadone-Maintained Patients: Can it be Treated? | Biotech Hunter | Biotech Hunter